Medical device company Zimmer Biomet (NYSE:ZBH) will be announcing earnings results this Tuesday before market open. Here’s ...

Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its G7 acetabular system for hip ...

Layoffs are underway at Warsaw-based orthopedic manufacturer Zimmer Biomet. Company officials say they are not disclosing the total number of employees affected, noting that most of the layoffs are ...

Zimmer Biomet Holdings Inc. reports fourth-quarter earnings Tuesday before the market opens, facing a critical test of whether the medical device maker can restore investor confidence after a bruising ...

Zimmer Biomet earns FDA clearance for the G7 Acetabular System, enabling U.S. commercialization of this advanced hip implant.

Zimmer Biomet (ZBH) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results ...

Over the past six months, Zimmer Biomet’s shares (currently trading at $86.64) have posted a disappointing 6.2% loss, well below the S&P 500’s 9.6% gain. This might have investors contemplating their ...

Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported better-than-expected earnings for the first quarter on Monday. The company posted first-quarter adjusted EPS of $1.81, down from $1.94 a year ago, ...

Zimmer Biomet Holdings, Inc. has a definitive agreement to acquire all outstanding shares of the AI-driven orthopedic robotics company Monogram Technologies Inc., an equity deal valued at $177 million ...

Zimmer and Biomet announced that their respective boards of directors have approved a definitive agreement, under which Zimmer will acquire Biomet in a transaction valued at approximately $13.35 ...